Arrillaga-Romany I, Lassman A, McGovern SL, Mueller S, et al. ACTION: A randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro Oncol 2024 Mar 6:noae031. doi: 10.1093.
PMID: 38445964